India, June 23 -- Indian pharmaceutical stocks are in focus in today's trading session after reports suggest rising interest from the US drug regulator. According to a Mint report citing sources, the USFDA has reportedly reached out to Indian drug makers amid a shortage of a key cancer treatment medicine in the US market.

The drug in question is ifofamide, which is used in the treatment of testicular, bladder, and lung cancers. The development highlights potential supply gaps in the US healthcare system and could create new opportunities for Indian pharmaceutical manufacturers to supply this critical oncology drug.

Supply Disruptions Trigger Global Shortage The reported shortage is attributed to technical problems at a manufacturing fac...